Skip to content

Heparin in Total Parenteral Nutrition to prevent sepsis in neonates with long lines: A Randomized Controlled Trial

Heparin in Total Parenteral Nutrition to prevent sepsis in neonates with long lines: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/08/002933
Enrollment
130
Registered
2012-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- neonates of either sex admitted in NICU, in whom a longline insertion is indicated for therapeutic reasons

Interventions

Intervention1: heparin infusion in long lines: Heparin 0.5IU/ml of TPN solution Control Intervention1: no heparin infusion in neonatal loglines: no Heparin infusion

Sponsors

Department of Pharmacology IPGMER Kolkata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Neonates of either sex admitted in the NICU in whom a longline insertion is therapeutically indicated. Parents of the neonates should provide written informed consent

Exclusion criteria

Exclusion criteria: Neonates in whom the blood culture report or septic screen is positive prior to insertion of longline Neonates in whom the blood culture becomes positive within 48 hours of insertion of the longline

Design outcomes

Primary

MeasureTime frame
Number of episodes of catheter related blood stream infectionTimepoint: Number of episodes of catheter related blood stream infection

Secondary

MeasureTime frame
ï?§ Number of bacteraemic episodes with organisms not commonly associated with line sepsis such as gram negative bacilli where the pathogenesis is not likely to be inhibited by heparin and microthrombi in the catheter tip is not expected to be a major nidus of infectionTimepoint: Number of episodes of catheter related blood stream infection

Countries

India

Contacts

Public ContactDr Suparna Chatterjee

Associate Professor, Dept of Pharmacology, IPGMER, Kolkata

drsupchat@gmail.com03322234135

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026